Immunotherapy in non-small cell lung cancer: current status, advances and challenges

被引：0
|
作者：
Tartarone, Alfredo [1 ]
Lerose, Rosa [2 ]
Tartarone, Marina [3 ]
机构：
[1] IRCCS CROB Referral Canc Ctr Basilicata, Dept Onco Hematol, Div Med Oncol, Via Padre Pio 1, I-85028 Rionero In Vulture, Potenza, Italy
[2] IRCCS CROB Referral Canc Ctr Basilicata, Hosp Pharm, Rionero In Vulture, Potenza, Italy
[3] Humanitas Univ, Milan, Italy
来源：
MINERVA RESPIRATORY MEDICINE | 2024年 / 63卷 / 03期
关键词：
Carcinoma; non-small-cell lung; Immunotherapy; Immune checkpoint inhibitors; NIVOLUMAB PLUS IPILIMUMAB; OPEN-LABEL; 1ST-LINE TREATMENT; BRAIN METASTASES; POOLED ANALYSIS; CHECKMATE; 9LA; PEMBROLIZUMAB; CHEMOTHERAPY; DOCETAXEL; PHASE-3;
D O I：
10.23736/S2784-8477.24.02108-9
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
In recent years, thanks to the advent of immunotherapy, the therapeutic landscape of non-oncogene-addicted non-small cell lung cancer (NSCLC) has undergone a complete revolution. So far, several monoclonal antibodies directed against PD-1, PD-L1, or CTLA-4, known as immune checkpoint inhibitors (ICIs), administered alone or in combination with other agents have shown efficacy in metastatic setting as well as, more recently, even in the early-stage. We reviewed the role of immunotherapy in NSCLC focusing the attention not only on the results of the main currently available clinical trials but also on novel combination strategies.
引用
下载
收藏
页码：110 / 120
页数：11
相关论文
共 50 条
  • [21] Current status of immunotherapy for non-small-cell lung cancer
    Imbimbo, Martina
    Lo Russo, Giuseppe
    Blackhall, Fiona
    TUMORI JOURNAL, 2016, 102 (04): : 337 - 351
  • [22] Immunotherapy in Advanced Non-Small Cell Lung Cancers: Current Status and Updates
    Suraya, Ratoe
    Tachihara, Motoko
    Nagano, Tatsuya
    Nishimura, Yoshihiro
    Kobayashi, Kazuyuki
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 2079 - 2090
  • [23] Immunotherapy for non-small cell lung cancer
    Vafadar, Sam
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2019, 32 (09): : 37 - 42
  • [24] Immunotherapy for Non-Small Cell Lung Cancer
    Yoon, Sung Ho
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2014, 77 (03) : 111 - 115
  • [25] Immunotherapy in non-small cell lung cancer
    Peters, Geoffrey
    John, Thomas
    CANCER FORUM, 2018, 42 (01) : 24 - 28
  • [26] Immunotherapy for non-small cell lung cancer
    Kagamu, Hiroshi
    RESPIRATORY INVESTIGATION, 2024, 62 (02) : 307 - 312
  • [27] Immunotherapy for Metastatic Non-Small Cell Lung Cancer: Therapeutic Advances and Biomarkers
    Russano, Marco
    La Cava, Giulia
    Cortellini, Alessio
    Citarella, Fabrizio
    Galletti, Alessandro
    Di Fazio, Giuseppina Rita
    Santo, Valentina
    Brunetti, Leonardo
    Vendittelli, Alessia
    Fioroni, Iacopo
    Pantano, Francesco
    Tonini, Giuseppe
    Vincenzi, Bruno
    CURRENT ONCOLOGY, 2023, 30 (02) : 2366 - 2387
  • [28] Non-small cell lung cancer: current treatment and future advances
    Zappa, Cecilia
    Mousa, Shaker A.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (03) : 288 - 300
  • [29] Neoadjuvant immunotherapy for operable non-small cell lung cancer: Lessons learned and current challenges.
    Cascone, Tina
    CANCER RESEARCH, 2021, 81 (13)
  • [30] Current status and future perspectives on immunotherapy in neoadjuvant therapy of resectable non-small cell lung cancer
    Liu, Xingyu
    Xing, Huifang
    Liu, Hongyu
    Chen, Jun
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 (04) : 335 - 343
12345